Bridging the Gap for Named Patient Access in South Korea
Named patient supply programs play a critical role in providing individual patients with access to medications not yet approved or available in their country. For patients with rare diseases, life-threatening conditions, or urgent medical needs, traditional pharmaceutical distribution channels often cannot provide timely access to essential treatments.
GNH India bridges this gap by offering specialised named patient supply services in South Korea, ensuring that patients who need immediate access to rare disease medications receive them through proper regulatory channels. From managing named patient use programs to navigating MFDS (Ministry of Food and Drug Safety) compliance requirements, we provide tailored solutions that prioritise patient safety, regulatory integrity, and rapid access to critical medications. Furthermore, we facilitate parallel import and alternative supply pathways to ensure that healthcare providers can secure a consistent supply of authentic medications even when domestic stocks are unavailable.
Our mission: Ensuring individual patient access to life-saving medications in South Korea through expert global sourcing, MFDS regulatory compliance, and patient-centric pharmaceutical supply solutions that meet the highest international standards.
Named Patient Supply Program: Key Advantages
환자 맞춤 공급 프로그램의 핵심 장점
What sets our named patient program apart in the South Korean market:
MFDS Compliance & Regulatory Excellence
Navigating South Korea's complex pharmaceutical regulatory landscape with expertise in MFDS approval pathways, named patient use program requirements, and import licensing procedures. Our comprehensive understanding of Korean regulations ensures seamless documentation, customs clearance, and patient access to medications not yet available in South Korea.
Streamlined Named Patient Supply Chain
Advanced GDP-compliant logistics and real-time tracking specifically designed for individual patient medication needs. We manage the entire supply chain from global sourcing to Korean hospital delivery, including temperature-controlled cold chain management, customs documentation, and direct coordination with Korean healthcare facilities to ensure medications reach patients safely and on time.
Patient-First Access Programs
Named patient supply programs exist to serve individual patients facing critical medical needs. We prioritise urgent patient access through compassionate use pathways, working closely with Korean physicians, hospitals, and regulatory authorities to expedite approvals and ensure patients receive life-saving treatments when every day counts. Our multilingual support team provides guidance in Korean and English throughout the entire process.
Custom Solutions for Korean Healthcare Institutions
Korean hospitals and healthcare providers face unique challenges accessing medications for named patient programs. We provide flexible, institution-specific solutions including MFDS regulatory consultancy, physician support for import applications, bilingual documentation services, emergency sourcing capabilities, and ongoing compliance assistance tailored to South Korea's pharmaceutical regulatory environment and healthcare system requirements.
Comprehensive Named Patient Supply Services
종합 환자 맞춤 공급 서비스
End-to-end named patient program solutions for South Korea's healthcare ecosystem:
Individual Named Patient Supply
Direct patient access to medications not approved in South Korea through proper physician prescription, medical justification, and MFDS compassionate use pathways for urgent, life-threatening, or rare disease cases.
MFDS Regulatory Documentation
Complete support for MFDS import authorisation applications including physician letters, patient medical justification, pharmaceutical quality certificates, and all required regulatory documentation in Korean and English for seamless approval.
Rare Disease Medication Access
Specialised sourcing of orphan drugs, ultra-rare disease treatments and specialty medications not available through Korean distribution channels, with expertise in global pharmaceutical supplier networks and manufacturer relationships.
Emergency Patient Access (24–72hr)
Crisis response for urgent, life-saving medication needs with expedited MFDS emergency use authorisation support, fast-track global sourcing, priority customs clearance, and express cold chain delivery to Korean hospitals.
Cold Chain & Specialty Handling
GDP-compliant temperature-controlled logistics for biologics, biosimilars, cell therapies, and temperature-sensitive medications requiring 2–8°C, −20°C, or −80°C storage with real-time monitoring and Korean customs validation.
Korean Language Support
Bilingual customer service team providing support in Korean and English for physicians, hospital procurement teams, patients, and families navigating the named patient supply process in South Korea.
Why Choose GNH India for South Korea?
왜 GNH India를 선택해야 할까요?
Unmatched Named Patient Program Expertise
Years of specialised experience providing named patient supply services globally, with deep understanding of South Korea's pharmaceutical regulatory framework and MFDS requirements for compassionate use and emergency access programs.
- Expert knowledge of MFDS named patient use program regulations
- Proven track record with Korean hospital partnerships
- Comprehensive understanding of Korean healthcare system requirements
- Multilingual support team (Korean/English)
Global Pharmaceutical Sourcing Network
Extensive relationships with pharmaceutical manufacturers, specialty distributors, and rare disease medication providers across 180+ countries, enabling rapid access to medications not available in South Korea through traditional channels.
- Direct manufacturer relationships for faster access
- Global network for ultra-rare medication sourcing
- Emergency sourcing capabilities (24–72 hour response)
- Access to medications approved by FDA, EMA, MHRA, and other international authorities
Regulatory & Quality Assurance Excellence
Named patient supply in South Korea demands strict adherence to MFDS regulations and international pharmaceutical quality standards. We maintain WHO-GSDP certification, ISO 9001:2015 compliance and follow all Korean import requirements.
- Full compliance with South Korean pharmaceutical import regulations
- WHO-GSDP and ISO 9001:2015 certified operations
- Complete documentation transparency for MFDS approval
- Ethical sourcing and quality assurance for all medications
Simple, Transparent Named Patient Supply Process
간단하고 투명한 환자 맞춤 공급 프로세스
From physician request to patient delivery — streamlined for South Korea:
Regulatory recognitions
Quality You Can Trust
Fully certified for named patient supply in South Korea with international quality standards.
